# Study to Evaluate Safety and Efficacy of Perioperative Chemotherapy With Docetaxel, Cisplatin and Capecitabine (DCX) in Patients With Gastro-esophageal Cancer

> **NCT00865982** · PHASE2 · UNKNOWN · sponsor: **Charite University, Berlin, Germany** · enrollment: 50 (estimated)

## Conditions studied

- Gastric Cancer
- Esophageal Cancer

## Interventions

- **DRUG:** Docetaxel, Cisplatin, Capecitabine

## Key facts

- **NCT ID:** NCT00865982
- **Lead sponsor:** Charite University, Berlin, Germany
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-09
- **Primary completion:** 2014-09
- **Final completion:** 2015-09
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2011-08-05

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00865982

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00865982, "Study to Evaluate Safety and Efficacy of Perioperative Chemotherapy With Docetaxel, Cisplatin and Capecitabine (DCX) in Patients With Gastro-esophageal Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00865982. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*